Randy MBA - Tharimmune Chairman President
| THAR Stock | 1.55 0.07 4.73% |
Chairman
Randy MBA is Chairman President of Tharimmune
| Age | 71 |
| Phone | 908 955 3140 |
| Web | https://www.tharimmune.com |
Tharimmune Management Efficiency
The company has return on total asset (ROA) of (1.6508) % which means that it has lost $1.6508 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5453) %, meaning that it created substantial loss on money invested by shareholders. Tharimmune's management efficiency ratios could be used to measure how well Tharimmune manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Christopher Coleman | Barrick Gold Corp | 51 | |
| Philip Knight | Nike Inc | 87 | |
| Graham Shuttleworth | Barrick Gold Corp | 56 | |
| Robert Patterson | Avient Corp | 51 | |
| John Thornton | Barrick Gold Corp | 70 | |
Management Performance
| Return On Equity | -4.55 | ||||
| Return On Asset | -1.65 |
Tharimmune Leadership Team
Elected by the shareholders, the Tharimmune's board of directors comprises two types of representatives: Tharimmune inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tharimmune. The board's role is to monitor Tharimmune's management team and ensure that shareholders' interests are well served. Tharimmune's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tharimmune's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randy MBA, Chairman President | ||
| Sireesh PharmD, COO Director |
Tharimmune Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tharimmune a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.55 | ||||
| Return On Asset | -1.65 | ||||
| Current Valuation | (263.36 K) | ||||
| Shares Outstanding | 1.93 M | ||||
| Shares Owned By Insiders | 1.61 % | ||||
| Shares Owned By Institutions | 7.71 % | ||||
| Number Of Shares Shorted | 26.34 K | ||||
| Price To Book | 0.91 X | ||||
| EBITDA | (9.3 M) | ||||
| Net Income | (9.32 M) |
Pair Trading with Tharimmune
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.Moving against Tharimmune Stock
| 0.5 | MGTX | MeiraGTx Holdings PLC | PairCorr |
| 0.46 | MDCX | Medicus Pharma Upward Rally | PairCorr |
| 0.45 | DOMH | Dominari Holdings Downward Rally | PairCorr |
| 0.43 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.
The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Tharimmune Stock Analysis
When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.